Quentin Sattentau

Professor of Immunology at Oxford University

[EAVI2020 @eavi2020]

Today is #WorldAIDSDay. We remember those lost too soon and the #EU-funded EAVI2020 research team work tirelessly to end new infections through critical research into an effective #HIV vaccine. A global epidemic requires a global effort. @EU_H2020

[EAVI2020 @eavi2020]

Dr Gabriel Scarlatti. "HIV affects still too many - children, adolescents & adults. An effective vaccine will make all the difference..." Dr. Scarlatti #HIV focus includes the pathogenic mechanism driving viral transmission at mucosal sites and B cell responses. @gabriel83657791

[EAVI2020 @eavi2020]

Dr Jill Gilmour. “2018 saw another 1.7 million new HIV infections...we need to drive this number to zero”. Dr Gilmour leads IAVI’s clinical laboratory program; building to support international #HIV vaccine trials and epidemiology studies.

[EAVI2020 @eavi2020]

Dr Pepe Alcami. "...The solution to AIDS will be collaborative or it will not be. The solution to AIDS will be solitary or it will not be". Dr Alcami looks at host restriction factors that block the viral life cycle & the interaction of #HIV with the immune system. @pepealcami

[EAVI2020 @eavi2020]

Prof. Rogier W. Sanders. “Working on an HIV vaccine...is working collaboratively towards that ultimate goal of finally realising a global health necessity.” Prof. Sanders helped to create an artificial variant of the protein responsible for #HIV antibodies.

[EAVI2020 @eavi2020]

Prof. Robin Shattock. “Work to develop an HIV vaccine is one of the biggest challenges...we’re doing it not because it's easy, but because it's needed”. Prof. Shattock leads international teams aimed to develop & select #HIV microbicide and vaccine candidates. @roboskis

[EAVI2020 @eavi2020]

Prof. Quentin Sattentatu “Making an HIV vaccine is a very tough call. But every year we get closer to the goal.” Dr Sattentau current research spans the fields of HIV-1 dissemination, HIV-1 antibody-based vaccine design, and the molecular basis of allergy.